Dupixent Approved to Treat Eczema

TUESDAY, March 28, 2017 — Dupixent (dupilumab) has been approved by the U.S. Food and Drug Administration to treat moderate-to-severe eczema that isn’t well controlled by topical medication.
Eczema, medically called atopic dermatitis, is a chronic…
Source: Topamax